Watch for revenue recognition from the $49.5M in purchase orders in 2026 and any updates on strategic alternatives. The stock may react positively if procurement conversions accelerate, but remains high-risk due to minimal current revenue and history of losses.
Price Chart
Executive Summary
Inspira Technologies reported minimal revenue of $289,000 in 2025 with a net loss of $13.22 million, reflecting ongoing commercialization challenges. Despite the weak financials, the company secured $49.5 million in binding purchase orders expected to drive revenue in 2026 and raised $4.75 million in a follow-on offering, improving liquidity and Nasdaq compliance. Clinical deployments are expanding, and the company is advancing its HYLA blood sensor platform.
Key Financial Metrics
Key Facts
- Reported $289,000 in revenue for 2025, up from $0 in 2024
- Net loss widened to $13.22 million in 2025 from $11.05 million in 2024
- Secured $49.5 million in binding purchase orders, with revenue expected in 2026
- Raised $4.75 million in a registered direct offering post-year-end
- Cash and equivalents dropped to $3.16 million from $5.78 million in 2024
- Appointed new VP of Global Sales and expanded clinical use at U.S. medical centers
- Terminated non-binding term sheet with Bio-View Ltd., evaluating other strategic options
Financial Impact
Revenue of $289,000 is negligible; $49.5M in future orders represents significant potential upside in 2026
Risk Factors
- Minimal current revenue and sustained losses raise sustainability concerns
- Revenue from $49.5M in orders is deferred and subject to procurement delays
- High share-based compensation and executive turnover may signal governance risks
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3263441 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 29, 2026 18w ago | Press Release | $3.07 $1.61 | ▼ −47.56% | ▼ −45.76% | — |
May 18, 2026 19w ago | Press Release | $0.3723 $1.29 | ▲ +245.15% | ▲ +243.57% | — |
May 11, 2026 20w ago | Press Release | $0.4070 $1.60 | ▲ +293.12% | ▲ +293.42% | — |
May 1, 2026 22w ago | Press Release | $0.4680 $3.07 | ▲ +555.98% | ▲ +550.70% | — |
Apr 16, 2026 24w ago | Press Release | $0.4950 $0.4050 | ▼ −18.18% | ▼ −24.00% | — |
Apr 14, 2026 24w ago | Press Release | $0.4750 $0.4070 | ▼ −14.32% | ▼ −20.61% | — |
Apr 13, 2026 24w ago | Press Release | $0.5080 $0.4070 | ▼ −19.88% | ▼ −27.61% | — |
Apr 6, 2026 25w ago | Press Release | $0.4110 $0.4780 | ▲ +16.30% | ▲ +7.32% | — |
Apr 6, 2026 25w ago | Press Release | $0.4110 $0.4780 | ▲ +16.30% | ▲ +7.32% | — |
Mar 31, 2026 26w ago | Press Release | $0.4470 $0.4787 | ▲ +7.09% | ▼ −2.33% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access